Sinew Pharma Inc. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 0.328 million compared to TWD 5.05 million a year ago. Net loss was TWD 61.82 million compared to TWD 37.83 million a year ago. Basic loss per share from continuing operations was TWD 0.9 compared to TWD 0.72 a year ago. Diluted loss per share from continuing operations was TWD 0.9 compared to TWD 0.72 a year ago. Basic loss per share was TWD 0.9 compared to TWD 0.72 a year ago. Diluted loss per share was TWD 0.9 compared to TWD 0.72 a year ago.